Talk about a surprise perk. Numerous additional benefits of GLP-1 weight loss drugs like Ozempic continue to be discovered, ...

For people with chronic migraine, taking glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, for other conditions such as diabetes and weight loss, was associated with fewer emergency ...

Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...

Study Confirms Safety of Using Theranica’s Nerivio REN Wearable for Treatment of Migraine Simultaneously with Contemporary Continuous Glucose Monitoring (CGM) Devices Published in the Journal of ...

Triangle Business Journal will recognize the robust growth of the Life Sciences sector in the Triangle. Nominations will be ...

Find out if the dull throbbing in your head is headache or migraine and how you can reduce the frequency.

NICE recommended rimegepant in 2023 for treating migraine and preventing episodic attacks (between 4 and 14 migraines per month), and atogepant in 2024 for preventing both episodic and chronic ...

As CGRP-targeted therapies move into wider use, new data are beginning to clarify their role in special populations, the value of switching agents when one fails, and their long-term vascular safety.

An NHS regulator highlighted the ‘rapid take-up’ of new migraine pills to stop a key protein which causes brain inflammation, as one patient says ‘they are life changing’ ...

The American Migraine Foundation (AMF), in partnership with the American Headache Society (AHS), has announced the launch of the Dodick Lighthouse Research Awards, a competitive research funding ...

Slate Medicines will move forward with a migraine drug from a Chinese biotech, while Alveus Therapeutics will advance a dual ...